Reckitt Benckiser: From Hold to Buy - An Investment Reassessment

by : Lisa Jing

Following a significant 30% drop in share price, Reckitt Benckiser Group plc, known by its tickers RBGPF and RBGLY, has received an upgraded investment rating, shifting from a 'Hold' to a 'Buy'. This reevaluation comes despite recent market challenges that have impacted the company's performance, suggesting that the current valuation offers an attractive entry point for investors. The underlying strength of the company’s core operations, particularly in expanding markets and through product innovation, underpins this optimistic outlook.

The management of Reckitt Benckiser has consistently guided towards a 4-5% like-for-like net revenue growth by the year 2026, indicating confidence in their strategic initiatives and market positioning. Furthermore, the company offers a compelling dividend yield exceeding 5%, excluding any special dividends, which is a significant factor for income-focused investors. While the payout ratios appear elevated, they are deemed sustainable given the potential for free cash flow recovery in the near future. The current trading multiples, at 9.4 times earnings and 17.6 times free cash flow, are notably below the company's historical averages, implying that the stock is intrinsically undervalued.

This revised perspective on Reckitt Benckiser highlights a potential opportunity for investors. The combination of a substantial share price correction, robust core business growth, an attractive dividend yield, and a discounted valuation against historical benchmarks points to a promising investment prospect. As market conditions evolve and the company continues to execute its strategy, there is a strong possibility for capital appreciation and steady income generation, aligning with a long-term growth and value investment philosophy.